Target intelligence / Profile preview

Class II fructose-bisphosphate aldolase

Molecular classification
Enzyme, Aldolase family, Lyase (specifically, carbon-carbon lyase), TIM barrel fold protein
01

Overview

Class II fructose-bisphosphate aldolase is an enzyme found predominantly in bacteria, fungi, and some protists, where it catalyzes a key glycolytic and gluconeogenic step—the reversible cleavage of fructose 1,6-bisphosphate into dihydroxyacetone phosphate and glyceraldehyde 3-phosphate[1][3][5][7]. Unlike class I aldolases (common in animals and plants), class II aldolases require a divalent metal ion, typically zinc, for catalysis, enabling polarization of the substrate carbonyl group[1][3][5]. The enzyme adopts a TIM barrel (α/β)_8 fold and features a bimetallic active site architecture[1]. Class II aldolase is of interest as a drug target in infectious diseases because it is absent in mammals; selective inhibitors (especially metal chelators) have been explored to block metabolic pathways in pathogens without affecting the host[6]. No widely used clinical inhibitors exist yet, but research focuses on such molecules for the treatment of bacterial, fungal, and protozoal infections[6].

Other names
Fructose-1,6-bisphosphate aldolase (Class II)FBP-aldolase (Class II)FBA (Class II)D-glyceraldehyde-3-phosphate lyase (Class II)EC 4.1.2.13 (Class II)
02

Mechanism of action

Inhibition by metal chelation (blocking divalent cation, usually zinc, required for enzymatic activity); Substrate analogs (competitive binding to active site)

03

Biological functions

Glycolysis (cleavage of fructose 1,6-bisphosphate)Gluconeogenesis (condensation of triose-phosphates)Carbon metabolism
04

Disease associations

Infection (target in bacterial and fungal pathogens)Other (pathogen metabolism)
05

Safety considerations

Potential off-target effects if inhibitors cross-react with human metalloenzymesDiscrepancy between pathogen and human aldolases (less concern for host toxicity due to different enzyme classes, but possible if compounds are not specific)
06

Interacting drugs

Experimental metal-chelating inhibitors (e.g., zinc chelators, hydroxamic acids; specific compound names not widely established for clinical use)

Beyond the preview

Go deeper on Class II fructose-bisphosphate aldolase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Class II fructose-bisphosphate aldolase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call